Maine urologist guilty of fraud
Compliance Monitor, October 13, 2004
Want to receive articles like this one in your inbox? Subscribe to Compliance Monitor!
Joseph Olstein, MD, was sentenced October 6 to one year of probation and a $20,000 fine following a guilty plea for conspiring to bill insurance companies for free samples of Lupron.
Olstein admitted to getting the samples from TAP Pharmaceutical Products sales representatives, according to a statement from Massachusetts U.S. Attorney Michael J. Sullivan.
If the sentence seems light, it's because Olstein assisted the government beginning in 1999 with its investigation of TAP through the U.S. Attorney General's office in Massachusetts, as well as an investigation of AstraZeneca by the U.S. Attorney's office in Delaware.
The two investigations were resolved with settlement agreements totaling more than $1.2 million.
To read more, click here.
Want to receive articles like this one in your inbox? Subscribe to Compliance Monitor!
Related Products
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Identify potential Medicaid RAC target areas
- HIPAA Q&A: Level of encryption needed for email
- Topic: CMS, OESS post new security compliance review information, checklist
- Capturing all necessary codes for IUD insertion and removal can be challenging
- What does case-mix index mean to you?
- OB services: Coding inside and outside of the package
- QA:Coding multiple initial infusions
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- CMS has reformulated payments for some bilateral procedures
- HIPAA Q&A: Level of encryption needed for email
- Q&A: Follow CMS' coding guidelines when using modifier -25
- What does case-mix index mean to you?
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- Q/A. One injection code or two?
- Cohesive History and Physical Requirements
- Searched
